Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West
- 07:30 - 11:30
- 10/15/2017
- Location: F203 (Annex Hall)
- Type: Joint Session IASLC/CSCO/CAALC
- Track: Immunology and Immunotherapy
- Moderators:C. Bai, Fred R. Hirsch, Tony SK Mok, Yi-Long Wu
-
+
JCSE 01.27 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial
11:30 - 11:30 | Presenter: Tony SK Mok | Author(s): Solange Peters, D. Ross Camidge, Shirish M Gadgeel, S.I. Ou, D. Kim, Rafal Dziadziuszko, F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch, T. Liu, I. Loftin, C. Williams, Alice Shaw
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-013 - Patient-Reported Outcomes and Safety from the Phase III ALUR Study of Alectinib vs Chemotherapy in Pre-Treated ALK+ NSCLC
09:30 - 09:30 | Presenter: Julien Mazieres | Author(s): Silvia Novello, J. De Castro, Maria Rita Migliorino, Å. Helland, Rafal Dziadziuszko, Frank Griesinger, Jürgen Wolf, A. Zeaiter, A. Cardona, B. Balas, T. Karagiannis, M. Chlistalla, V. Smoljanovic, I. Oh
- Abstract
Loading...
-
+
P1.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P1.04-011 - Development of Novel Blood-Based Biomarker Assays in 1L Advanced/ Metastatic NSCLC: Blood First Assay Screening Trial (BFAST)
09:30 - 09:30 | Presenter: Tony SK Mok | Author(s): Rafal Dziadziuszko, Solange Peters, X. He, T. Riehl, E. Schleifman, S.M. Paul, S. Mocci, D.S. Shames, M. Mathisen, Shirish M Gadgeel
- Abstract
Loading...
-
+
MA 06 - Lung Cancer Biology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:N. Motoi, Keith M Kerr
-
+
MA 06.06 - Assessment of RANK Prevalence and Clinical Significance in the NSCLC European Thoracic Oncology Platform Lungscape Cohort
16:20 - 16:25 | Presenter: Erik Thunnissen | Author(s): U. Dafni, Lukas Bubendorf, A. Warth, W. Biernat, S. Pokharel, Rafal Dziadziuszko, H. Dienemann, R. Cheney, N. Marti, M. Kassapian, Stephen P Finn, Keith M Kerr, R. Kammler, Rolf A Stahel, Solange Peters, F. Etop Lungscape
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
16:50 - 17:00 | Presenter: Byoung Chul Cho | Author(s): R. Obermannová, A. Bearz, D. Kim, S. Orlov, G. Borra, Sang-We Kim, Pieter E. Postmus, S.A. Laurie, Keunchil Park, S.L. Geater, A.C. Bettini, K. Osborne, V.Q. Passos, Z. Chen, Rafal Dziadziuszko
- Abstract
Loading...
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.01 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial
15:45 - 15:50 | Presenter: Tony SK Mok | Author(s): Solange Peters, D. Ross Camidge, Shirish M Gadgeel, S. Ignatius Ou, D. Kim, Rafal Dziadziuszko, F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch, T. Liu, Isabell Loftin, C. Williams, Alice Shaw
- Abstract
Loading...
-
+
PC 03 - 3-1 What is the Optimal Sequence of ALK-TKI for ALK-Positive Lung Cancer? (Alectinib First or Crizotinib First)
- 11:00 - 11:40
- 10/18/2017
- Location: Room 303 + 304
- Type: Pros & Cons
- Track: Chemotherapy/Targeted Therapy
- Moderators:Rafal Dziadziuszko, Y.O. Tan
-
+
PC 03.01 - Crizotinib First
11:00 - 11:20 | Presenter: Sai-Hong Ignatius Ou
- Abstract
Loading... -
+
PC 03.02 - Alectinib First
11:20 - 11:40 | Presenter: Kazuhiko Nakagawa
- Abstract
No abstract available for this presentation
-
+
PC 03 - 3-2 Which Do you Prefer: Liquid Biopsy or Tissues Biopsy for Molecular Diagnosis?
- 11:40 - 12:30
- 10/18/2017
- Location: Room 303 + 304
- Type: Pros & Cons
- Track: Chemotherapy/Targeted Therapy
- Moderators:Rafal Dziadziuszko, Y.O. Tan
-
+
PC 03.03 - Liquid Biopsy
11:40 - 12:00 | Presenter: Heather A Wakelee
- Abstract
Loading... -
+
PC 03.04 - Tissues Biopsy
12:00 - 12:20 | Presenter: Keith M Kerr
- Abstract
No abstract available for this presentation
-
+
PC 03.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
ES 10 - Radiation Treatment Update
- 14:30 - 16:15
- 10/18/2017
- Location: F201 + F202 (Annex Hall)
- Type: Educational Session
- Track: Radiotherapy
- Moderators:Z. Liao, F. McDonald
-
+
ES 10.05 - RT and Targeted Therapies
15:50 - 16:10 | Presenter: Rafal Dziadziuszko
- Abstract
No abstract available for this presentation